Neoplastic transformation of cells by soluble but not particulate forms of metals used in orthopaedic implants

Biomaterials

Volumn 19, Issue 7-9, 1998, Pages 751-759

  Doran, A ^a   Law, F C ^a   Allen, M J ^b   Rushton, N ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

C3H10T 1 4; Metals; Neoplasia; Particles; Soluble ions; Transformation

Indexed keywords

ALLOYS; CELLS; METALS; PARTICLES (PARTICULATE MATTER); SALTS; SOLUBILITY; TOXICITY;

NEOPLASTIC TRANSFORMATION;

IMPLANTS (SURGICAL);

ALLOY; ALUMINUM; CHROMIUM; COBALT; IRON; METAL; MOLYBDENUM; NICKEL; STAINLESS STEEL; TITANIUM; VANADIUM;

ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL TRANSFORMATION; FIBROBLAST CULTURE; IMPLANT; PARTICULATE MATTER; PRIORITY JOURNAL; SOLUBILIZATION;

ALLOYS; ANIMALS; BIOCOMPATIBLE MATERIALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CHROMIUM ALLOYS; FIBROBLASTS; METALS; MICE; MICE, INBRED C3H; ORTHOPEDIC FIXATION DEVICES; PROSTHESES AND IMPLANTS; SALTS; SOLUBILITY; STAINLESS STEEL; TITANIUM;

EID: 0032052665     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(97)00209-3     Document Type: Article

References (58)

1. [1] Black J. Does corrosion matter? J Bone Jt Surg [Br] 1988; 70-B:517-20.
2. [2] Skipor AK, Jacobs JJ, Paprosky WP, Patterson, LM, Black J, Galante JO. Serum and urine chromium concentrations in patients with cobalt-chromium THR components. Trans Orthop Res Soc 1996;21:46.
3. [3] Jacobs JJ, Skipor AK, Doorn PF et al. Cobalt and chromium concentrations in patients with metal on metal total hip replacemements. Clin Orthop 1996;329S:S256-63.
4. [4] Chovil A, Sutherland RB, Halliday M. Respiratory cancer in a cohort of nickel sinter plant workers. Br J Ind Med 1981;38: 327-33.
5. [5] Satoh K, Fukada Y, Torii K, Katsumo N. Epidemiological study of workers engaged in the manufacture of chromium compounds. J Occup Med 1981;23:835-8.
6. [6] Sunderman FWJ. Carcinogenic effects of metals. Fed Proc 1978;37:40-6.
7. [7] Sunderman FWJ. Recent advances in metal carcinogenesis. Ann Clin Lab Sci 1984;14:93-122.
8. [8] Swanson SAV, Freeman MAR, Heath JC. Laboratory tests on total joint replacement prostheses. J Bone Jt Surg [Br] 1973;55-B: 759-73.
9. [9] Lewis CG, Plowman MC, Hopfer SM, Knight JA, Sunderman FWJ. Intraarticular carcinogenesis bioassays of CoCrMo and TiAlV alloys in rats. J Arthroplasty 1995;10:75-82.
10. [10] Jacobs JJ, Rosenbaum DH, Hay RM, Gitelis S, Black J. Early sarcomatous degeneration near a cementless hip replacement. A case report and review. J Bone Jt Surg [Br] 1992; 74-B:740-4.
11. [11] Apley AG. Malignancy and joint replacement: the tip of an iceberg? (Editorial). J Bone Jt Surg [Br] 1989;71-B:1.
12. [12] Goodfellow J. Malignancy and joint replacement. (Editorial). J Bone Jt Surg [Br] 1992;74-B:645.
13. [13] Gillespie WJ, Frampton CMA, Henderson RJ, Ryan PM. The incidence of cancer following total hip replacement. J Bone Jt Surg [Br] 1988;70-B:539-42.
14. [14] Visuri T, Koskenvuo M. Cancer risk after McKee-Farrar total hip replacement. Orthopaedics 1991;14:137-42.
15. [15] Mathiesen EB, Ahlbom A, Bermann G, Lindgren JU. Total hip replacement and cancer. A cohort study. J Bone Jt Surg [Br] 1995;77-B:345-50.
16. [16] Nyren O, McLaughlin JK, Gridley G et al. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst 1988;87:28-33.
17. [17] Gillespie WJ, Henry DA, O'Connell DL et al. Development of hematopoietic cancers after implantation of total joint replacement. Clin Orthop 1996;329S:S290-S296.
18. [18] Hueper W. Experimental studies in metal carcinogenesis. VII. Tissue reactions to parenterally introduced powdered metallic chromium and chromite ore. J Natl Cancer Inst 1955; 16:447-69.
19. [19] Gaechter A, Alroy J, Anderson GB, Galante J, Rostoker W, Schajowicz F. Metal carcinogenesis. A study of the carcinogenic activity of solid metal alloys in rats. J Bone Jt Surg [Am] 1977;59-A:622-4.
20. [20] Meachim G, Pedley RB, Williams DF. A study of sarcogenicity associated with Co-Cr-Mo particles implanted in animal muscle. J Biomed Mater Res 1982;16:407-16.
21. [21] Oppenheimer BS, Oppenheimer E, Danishefsky I, Stout AP. Carcinogenic effects of metals in rats. Cancer Res 1956; 16:439-41.
22. [22] Heath JC, Freeman MAR, Swanson SAV. Carcinogenic properties of wear particles from prostheses made in cobalt-chromium alloy. The Lancet 1971;1:564-6.
23. [23] Reznikoff CA, Brankow DW, Heidelberger C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 1973;33:3231-38.
24. [24] Reznikoff CA, Bertram JS, Brankow DW, Heidelberger C. Qualitative and quantitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 1973;33:3239-49.
25. [25] Landolph JR. Chemical transformation in C3H10T1/2 Cl 8 mouse embryo fibroblasts: historical background, assessment of the transformation assay, and evolution and optimization of the transformation assay protocol. In: Kakunaga T, Yamasaki H, editors, Transformation Assay of Established Cell Lines: Mechanisms and Application. Lyon.: International Agency for Research on Cancer (IARC), 1985;185-201.
26. [26] Oshiru Y, Balwierz PS, Piper CE. Selection of foetal bovine serum for use in the C3H10T1/2 cell transformation assay system. Environ Mol Mutagen 1982;4:569-74.
27. [27] Costa M, Mollenhauer H. Carcinogenic activity of nickel compounds is proportional to their cellular uptake. Science 1980;209:515-17.
28. [28] Patierno SR, Banh D, Landolph JR. Transformation of C3H10T1/2 mouse embryo cells to focus formation and anchorage independent growth by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res 1988;48: 5280-88.
29. [29] Agins HJ, Alcock NW, Bansal M et al. Metallic wear in failed titanium-alloy total hip replacements. A histological and quantitative analysis. J Bone Jt Surg [Am] 1988;70-A:347-56.
30. [30] Betts F, Wright T, Salvati EA, Boskey A, Bansal M. Cobalt-alloy metal debris in periarticular tissues from total hip revision arthroplasties. Clin Orthop 1992;276:75-82.
31. [31] Coleman RF, Herrington J, Scales JT. Concentrations of wear products in hair, blood and urine after total hip replacement. Br Med J 1973;1:527-29.
32. [32] Henning FF, Raithel HJ, Schaller KH, Dohler JR. Nickel, chrome and cobalt concentrations in human tissue and body fluids of hip prosthesis patients. J Trace Elements Electrolytes in Health Dise 1992;6:239-43.
33. [33] Brodner W, Bitzan P, Meisinger V, Kaider A, Gottsauner-Wolf F, Kotz R. Elevated serum cobalt with metal-on-metal articulating surfaces. J Bone Jt Surg [Br] 1997;79-B:316-21.
34. [34] Willert H-G, Semlitsch M. Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res 1977;11:157-64.
35. [35] Howie DW, Vernon-Roberts B. Long-term effects of intraarticular cobalt-chrome alloy wear particles in rats. J Arthroplasty 1988;3:327-36.
36. [36] Jasty M, Floyd WE, Schiller AL, Goldring SR, Harris WH. Localized osteolysis in stable, non-septic total hip replacement. J Bone Jt Surg [Am] 1986;68-A:912-19.
37. [37] Murray DW, Rushton N. Macrophages stimulate bone resorption when they phagocytose particles. J Bone Jt Surg [Br] 1990;72-B:988-92.
38. [38] Yang J, Shanbhag AS, Lilien J, Black J. Human neutrophil response to short-term exposure to F-75 cobalt-based alloy. J Biomed Mater Res 1992;26:185-95.
39. [39] Gray MH, Talbert ML, Talbert WM, Bansal M, Hsu A. Changes seen in lymph nodes draining the sites of large joint prostheses. Am J Surg Pathol 1989;13:1050-56.
40. [40] Case CP, Langkamer VG, James C et al. Widespread dissemination of metal debris from implants. J Bone Jt Surg [Br] 1994;76-B:701-12.
41. [41] Merritt K, Brown SA. Distribution of cobalt chromium wear and corrosion products and biologic reactions. Clin Orthop 1996;329S:S233-43.
42. [42] Howie DW, Rogeers SD, McGee MA, Haynes DR. Biologic effects of cobalt chrome in cell and animal models. Clin Orthop 1996;329S:S217-32.
43. [43] Rae T. The toxicity of metals used in orthopaedic prostheses. An experimental study using cultured human synovial fibroblasts. J Bone Jt Surg [Br] 1981;63-B:435-40.
44. [44] Maloney WJ, Smith RL, Castro F, Schurman DJ. Fibroblast response to metallic debris in vitro. J Bone Jt Surg [Am] 1993;75-A:835-44.
45. [45] Rae T. The biological response to titanium and titanium-aluminium-vanadium alloy particles. I. Tissue culture studies. Biomaterials 1986;7:30-6.
46. [46] Waters MD, Gardner DE, Aranyi C, Coffin DL. Metal toxicity for rabbit alveolar macrophages in vitro. Environ Res 1975;9: 32-47.
47. [47] Wataha JC, Hanks CT, Sun Z. In vitro reaction of macrophages to metal ions from dental biomaterials. Dent Mater 1995;11: 239-45.
48. [48] Daniel M, Dingle JT, Webb M, Heath JC. The biological action of cobalt and other metals. I. The effect of cobalt on the morphology and metabolism of rat fibroblasts in vitro. Br J Exp Path 1963;44: 163-68.
49. [49] Puleo DA, Huh WW. Acute toxicity of metal ions in cultures of osteogenic cells derived from bone marrow stromal cells. J Appl Biomater 1995;6:109-16.
50. [50] McKay GC, Macnair R, MacDonald C, Grant MH. Interactions of orthopaedic metals with an immortalized rat osteoblast cell line. Biomaterials 1996;17:1339-44.
51. [51] Miura T, Patierno SR, Sakuramoto T, Landolph JR. Morphological and neoplastic transformation of C3H10T1/2 Cl. 8 mouse embryo cells by insoluble carcinogenic nickel compounds. Environ Mol Mutagen 1989;14:65-78.
52. [52] Heck JD, Costa M. Influence of surface charge and dissolution on the selective phagocytosis of potentially carcinogenic particulate metal compounds. Cancer Res 1983;43:5652-56.
53. [53] DiPaulo JA, Casto BC. Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res 1979;39:1008-13.
54. [54] Costa M, Salnikow K, Cosentino S, Klein CB, Huang X, Zhuang Z. Molecular mechanisms of nickel carcinogenesis. Environ Health Perspect 1994;102:127-30.
55. [55] Manning FCR, Blankenship LJ, Wise JP, Xu J, Bridgewater LC, Patierno SR. Induction of internucleosomal DNA fragmentation by carcinogenic chromate: relationship to DNA damage, genotoxicity, and inhibition of macromolecular synthesis. Environ Health Perspect 1994;102:159-67.
56. [56] Costa M, Heck JD, Robison SH. Selective phagocytosis of crystalline metal sulfide particles and DNA strand breaks as a mechanism for the induction of cellular transformation. Cancer Res 1982;42:2757-63.
57. [57] Sabbioni E, Pozzi G, Fintar A, Casella L, Garattini S. Cellular retention, cytotoxicity and morphological transformation by vanadium (IV) and vanadium (V) in BALB/3T3 cell lines. Carcinogenesis 1991;12:47-52.
58. [58] Merritt K, Brown SA. Release of hexavalent chromium from corrosion of stainless steel and cobalt-chromium alloys. J Biomed Mater Res 1995;29:627-33.